Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Navitoclax inhibits senescence in human alveolar type 2 cells from COPD patients — Yiling Guo (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Navitoclax inhibits senescence in human alveolar type 2 cells from COPD patients
Shared by
Peter J Barnes
Imperial College London
Navitoclax inhibits senescence in human alveolar type 2 cells from COPD patients
Article
2024
en
Authors
+3 more
YG
Yiling Guo
PF
Peter Fenwick
PV
Patrizia Viola
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2024
Navitoclax inhibits senescence markers in precision cut lung slices from COPD patients
Peter Fenwick
,
Justine Devulder
,
May Al‐Sahaf
,
Patrizia Viola
,
Peter J Barnes
,
Louise Donnelly
Article
2021
Alveolar type II cells harbouring SARS-CoV-2 show senescence with a proinflammatory phenotype
Koralia Paschalaki
,
Konstantinos Evangelou
,
Dimitris Veroutis
,
Periklis Foukas
,
Christos Kittas
,
Athanasios G. Tzioufas
,
Laurence de Leval
,
Demetris Vassilakos
,
Peter J Barnes
,
Vassilis G. Gorgoulis
Article
2022
Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD
Koralia Paschalaki
,
Christos Rossios
,
Charis Pericleous
,
Mairi Macleod
,
Stephen Rothery
,
Gavin C. Donaldson
,
Jadwiga A. Wedzicha
,
Vassilis G. Gorgoulis
,
Anna M. Randi
,
Peter J Barnes
Article
2025
BCLXL-PROTAC as a senolytic therapy in COPD alveolar type II cells
Yiling Guo
,
Peter Fenwick
,
Louise Donnelly
,
Peter J Barnes
Article
2022
Extracellular vesicles produced by airway epithelial cells from COPD patients contain miRNAs involved in cellular senescence
Justine Devulder
,
Jonathan Baker
,
Susan J. Monkley
,
Lina Odqvist
,
Louise Donnelly
,
Peter J Barnes
Discussion(0)
No comments yet. Be the first to comment.